Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
vinca alkaloid |
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:approvedBy |
gptkb:France
|
| gptkbp:ATCCode |
L01CA04
|
| gptkbp:CASNumber |
56124-62-0
|
| gptkbp:compatibleWith |
gptkb:United_States
|
| gptkbp:derivedFrom |
gptkb:Catharanthus_roseus
|
| gptkbp:discoveredBy |
gptkb:Pierre_Potier
|
| gptkbp:drugClass |
antineoplastic agent
|
| gptkbp:hasMolecularFormula |
C43H55N5O7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Eldisine
|
| gptkbp:mechanismOfAction |
inhibits microtubule formation
|
| gptkbp:sideEffect |
nausea
vomiting neurotoxicity myelosuppression |
| gptkbp:synonym |
gptkb:vindesine
|
| gptkbp:usedFor |
gptkb:cancer
|
| gptkbp:bfsParent |
gptkb:Vinorelbine
|
| gptkbp:bfsLayer |
7
|